FLAMEL TECHNOLOGIES S.A. (FLML) Files An 8-K Regulation FD Disclosure

On November 16, 2016, Flamel Technologies S.A. (the Company)
intends to make a presentation at Jefferies 2016 Healthcare
Conference in London, England. A copy of the Companys complete
slide presentation to be used at the Conference is being
furnished as Exhibit 99.1 to this Current Report on Form 8-K. The
Companys presentation will be webcast live and can be accessed by
visiting the Investor section of the Companys website at
http://www.flamel.com/investors. A replay of the presentation,
together with the complete slide presentation, will also be
available and archived for at least 30 days on the website
following the event.

The information responsive to Item 7.01 of this Form 8-K,
including Exhibit 99.1, shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934 (the Exchange
Act) or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act, except as may be
expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits